SERUM HBSAG LEVELS DURING PEGINTERFERON ALFA-2A TREATMENT IN HBEAG-POSITIVE CHRONIC HEPATITIS B: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Kim, Bo Hyun [1 ,2 ]
Kim, Won [3 ]
Song, Fun Young [4 ]
Park, Myoung Hee [4 ]
Yoon, Jung-Hwan [5 ,6 ]
Lee, Youn Jae [7 ]
Park, Sung Jae [7 ]
Jung, Eun Uk [7 ]
Kim, Donghee [8 ]
Kim, Yoon Jun [5 ,6 ]
Lee, Hyo-Suk [5 ,6 ]
机构：
[1] Bundang Jesaeng Gen Hosp, Dept Internal Med, Songnam, South Korea
[2] Bundang Jesaeng Gen Hosp, Hepatol Ctr, Songnam, South Korea
[3] Seoul Metropolitan Govt Seoul Natl Univ Boramae M, Dept Internal Med, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[6] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
[7] Inje Univ, Paik Hosp, Dept Internal Med, Pusan, South Korea
[8] Seoul Natl Univ Hosp, Gangnam Healthcare Ctr, Inst Healthcare Res, Seoul 110744, South Korea
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
390
引用
收藏
页码：514A / 514A
页数：1
相关论文
共 50 条
  • [41] Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine
    Song, K
    Rajvanshi, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (15): : 1630 - 1630
  • [42] HBSAG DECLINE DURING PEGINTERFERON ALFA-2B THERAPY FOR HBEAG-POSITIVE CHRONIC HEPATITIS B DEPENDS ON HBV GENOTYPE: RELATION TO SUSTAINED RESPONSE
    Sonneveld, Milan J.
    Rijckborst, Vincent
    Senturk, Hakan
    Zeuzem, Stefan
    Akarca, Ulus S.
    Simon, Krzysztof
    Gerken, Guido
    Boucher, Charles A.
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2010, 52 (04) : 539A - 540A
  • [43] Significance of T-Cell Subsets for Clinical Response to Peginterferon Alfa-2a Therapy in HBeAg-Positive Chronic Hepatitis B Patients
    Zhu, Li
    Li, Jin
    Xu, Junchi
    Chen, Fan
    Wu, Xunxun
    Zhu, Chuanwu
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 4441 - 4451
  • [44] Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
    Peng, C. -Y.
    Lai, H. -C.
    Li, Y. -F.
    Su, W. -P.
    Chuang, P. -H.
    Kao, J. -T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (04) : 458 - 468
  • [45] HIGH LEVELS OF HBSAG AND HBV DNA DURING TREATMENT PREDICT FAILURE FOR HBEAG SEROCONVERSION IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA); AN INTERIM ANALYSIS
    Takkenberg, Bart
    Zaaijer, Hans L.
    de Niet, Annikki
    Weegink, Christine J.
    Terpstra, Valeska
    Koot, Maarten
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Janssen, Harry L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2009, 50 (04) : 541A - 541A
  • [46] TREATMENT OF CHRONIC HBEAG-POSITIVE HEPATITIS WITH ACYCLOVIR - A CONTROLLED TRIAL
    GUARASCIO, P
    DEFELICI, AP
    MIGLIORINI, D
    ALEXANDER, GJM
    FAGAN, EA
    VISCO, G
    JOURNAL OF HEPATOLOGY, 1986, 3 : S143 - S147
  • [47] Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B
    Pfefferkorn, Maria
    Schott, Tina
    Boehm, Stephan
    Deichsel, Danilo
    Felkel, Christin
    Gerlich, Wolfram H.
    Glebe, Dieter
    Wat, Cynthia
    Pavlovic, Vedran
    Heyne, Renate
    Berg, Thomas
    van Boemmel, Florian
    JOURNAL OF HEPATOLOGY, 2021, 74 (02) : 283 - 292
  • [48] Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2a
    Rinker, Franziska
    Bremer, Corinna M.
    Schroeder, Kathrin
    Wiegand, Steffen B.
    Bremer, Birgit
    Manns, Michael P.
    Kraft, Anke R.
    Wedemeyer, Heiner
    Yang, Lei
    Pavlovic, Vedran
    Wat, Cynthia
    Gerlich, Wolfram H.
    Glebe, Dieter
    Cornberg, Markus
    LIVER INTERNATIONAL, 2020, 40 (02) : 324 - 332
  • [49] Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels
    Rijckborst, Vincent
    Hansen, Bettina E.
    Cakaloglu, Yilmaz
    Ferenci, Peter
    Tabak, Fehmi
    Akdogan, Meral
    Simon, Krzysztof
    Akarca, Ulus S.
    Flisiak, Robert
    Verhey, Elke
    Van Vuuren, Anneke J.
    Boucher, Charles A. B.
    ter Borg, Martijn J.
    Janssen, Harry L. A.
    HEPATOLOGY, 2010, 52 (02) : 454 - 461
  • [50] Cytokine Profiles and Virological Marker Monitoring during 48 Weeks Peginterferon Alfa Treatment for HBeAg-Positive Chronic Hepatitis B
    Li Ming Hui
    Sun Fang Fang
    Chen Feng Xin
    Zeng Zhan
    Lin Yan Jie
    Bi Xiao Yue
    Yang Liu
    Deng Wen
    Jiang Ting Ting
    Huang Rong Hai
    Yi Wei
    Xie Yao
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2022, 35 (04) : 312 - 321
12345